周三,2017年12月13日
类别:
Choose your language: English Español Français Português Italiano Deutsch Pусский हिन्दी 日本の 中国 한국어

美国银行:股市有一个领域超过其余

36

Scientists researchers laboratory biotech U.S. Army RDECOM / Flickr

  • Out of all the most appealing areas of the US stock market, Bank of America Merrill Lynch identifies biotech as the No. 1 option.
  • The firm likes biotech’s ideal combination of relatively cheap valuation, high expected growth and considerable upside potential.

Right now, it seems like there’s opportunity in the stock market no matter where you look.

Tech companies are surging to yet another series of record highs following blockbuster earnings reports for many of the sector’s mega-cap titans. Wall Street strategists are getting more bullish on banks as rate hikes loom. And that’s not to mention the stocks set to benefit most from tax reform

But Bank of America Merrill Lynch sees one industry standing above them all: biotech

To them, drug developers offer an ideal combination of attractive pricing and upside growth — unlike their tech stock counterparts, which are sitting near the most expensive on record. BAML also likes the upside offered by biotech based on how traders are currently positioned on the sector, especially when compared to the crowded tech trade.

Back in late September, BAML head US equity strategist Savita Subramanian wrote the following about drug developers: “Biotech trades at one of the biggest discounts to history of all industries, suggesting over 40% implied upside if its relative P/E reverted back to its long-term average.”

An update of that analysis shows that biotech now has an implied potential upside of 42%.

Here’s a list of BAML’s best sector opportunities:

Screen Shot 2017 10 30 at 12.28.15 PM Biotech is the best opportunity in the stock market, says BAML. 美银美林

Another area of the stock market that BAML highlighted in a recent client note is consumer staples. While the firm still only has the equivalent of a neutral rating on the space, it notes that it’s trading at the most attractive valuation in 6 1/2 years.

“Today, staples now looks cheap versus history,” Subramanian wrote in a client note on Monday. “Coupled with its earnings resiliency during downturns, staples is currently our preferred defensive sector after our overweight healthcare.”

Screen Shot 2017 10 30 at 12.34.59 PM 美银美林

en

WordPress的

分享

我们是一个系统的工作,以提高网站的质量,并通过检查文章,新闻和质量奖励活跃用户,非常感谢您改善 Business Monkey News!

如果该项目是错误的,这错译或丢失的信息,您可以编辑它,通知评论(我们将更正),也可以 查看原文章在这里: (原语言条)

这些变化将在2小时内进行更新。

编辑故事